ARC vs. Traditional Research
Comparisons Between ARC vs. Traditional Research
Here are comparisons between the Myelin Repair Foundation Accelerated Research Collaboration™ (ARC™) model for research and traditional research:
|
Accelerated Research Collaboration (ARC) Model |
Traditional Model |
|---|---|
| ARC™ brings together a world-class team of research scientists and provides them with a collaboration infrastructure in which discoveries are shared immediately without the delays associated with the publication of scientific papers. | Given that the “currency” of scientific research is ideas, few scientists share results until they have completed their experiments and published the results of their work. For complex diseases like multiple sclerosis which require multiple experiments in multiple areas, progress is extraordinarily slow. |
| ARC™ scientific team designs experiments that are part of a larger research plan focused on identifying therapeutic targets that will lead to patient treatments. | Individual experiments are conducted with scientific discovery in mind, not patient treatments. |
| ARC™ is based on building relationships with pharmaceutical companies to encourage further drug development and clinical trials. | There are no formal ties between academic science and the pharmaceutical industry. |
| The ARC™ model provides a framework for establishing membership and technology transfer agreements with each participating university. Patents are filed on all discoveries that may contribute to potential treatments. | Poor intellectual property protection discourages pharmaceutical companies from conducting further drug development and clinical trials. |
| The outcome of ARC™-based scientific research is leading directly to patient treatments. | The outcome for traditional scientific research is most often the publication of results. |
To learn more about how the ARC model works and what sets it apart from traditional research methods: Download Accelerated Research Collaboration: Driving Discoveries to Treatments (PDF).
Your Donation Matters
Our work is made possible by the generous donations of individuals, foundations and corporations who believe in the promise of myelin repair and share our commitment to deliver a new treatment to MS patients as fast as possible.
Please help us maintain our momentum. Your gift today will help us reach the first myelin repair Phase I Clinical Trial by 2014.
Making Connections for a Cure
Learn More: Find out what makes us different. Watch Making Connections for a Cure.
Download our accompanying brochure and share with friends.
Stay Up To Date on MRF’s News and Research
Sign up to receive our FREE newsletter, MyelinConnection, via email.
